Source: Nissen SE, et al. Joint American College of Cardiology/Journal of the American Medical Association Late-Breaking Clinical Trials. Presented at: American College of Cardiology Scientific Session; May 15-17, 2021 (virtual meeting).
AstraZeneca funded the STRENGTH trial. Nissen reports he has received institutional research grants from AbbVie, Amgen, AstraZeneca, Eli Lilly, Esperion, Ethicon Endosurgery, Medtronic, Novartis, Orexigen, Pfizer, Resverlogix, Takeda…